Study details
Enrolling now
Young HEROES Trial
The University of Texas Health Science Center, Houston
NCT IDNCT04811014ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
250
Study length
about 9.4 years
Ages
13–17
Locations
1 site in TX
About this study
This trial is testing a new way to help young people with opioid use disorder. It involves outreach, medication, counseling, and peer support to see if it helps them stay engaged in treatment and reduces overdoses.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Assertive Outreach
- 2.Participate in Individual Counseling
- 3.Participate in Peer Recovery Support Services
- +3 more
PhasePhase 4
DrugBuprenorphine
Routeinjection
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
buprenorphine, opioid partial agonist (Partial opioid agonist; relieves pain and treats opioid dependence), opioid antagonist (Opioid antagonist; blocks opioid receptors)
Drug routes
injection, sublingual (Sublingual Tablet)
Body systems
Psychiatry / Mental Health